News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bioMerieux To License Applied NeuroSolutions, Inc.'s (HMYD) Technology To Diagnose Alzheimer's Disease



10/19/2005 5:12:28 PM

VERNON HILLS, Ill.--(BUSINESS WIRE)--Dec. 15, 2004-- Applied NeuroSolutions, Inc. (OTCBB:APNS) (www.appliedneurosolutions.com), headquartered here, said today it signed a non-exclusive agreement with bioMerieux, S.A. (Euronext: FR0010096479 - BIM) with the aim of bringing to market on a worldwide basis what is expected to be the first definitive biologic test for the diagnosis of Alzheimer's disease ("AD").

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES